Scan to Download
One power score. Smarter investment decisions
Apimeds Pharmaceuticals US Inc
APUS2.020USD
+0.190+10.38%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
25.40MMarket Cap
LossP/E TTM
Apimeds Pharmaceuticals US Inc
2.020
+0.190+10.38%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
Total equity
Cash, cash equivalents and short-term investments
13694.21%8.74M
69.86%250.34K
-99.16%3.46K
-96.46%26.57K
--63.33K
--147.38K
--410.48K
--751.05K
- Cash and cash equivalents
13694.21%8.74M
69.86%250.34K
-99.16%3.46K
-96.46%26.57K
--63.33K
--147.38K
--410.48K
--751.05K
Prepaid expenses
15517.51%1.61M
-7.50%9.56K
-17.19%9.60K
-93.98%10.34K
--10.34K
--10.34K
--11.60K
--171.67K
Total current assets
13950.05%10.35M
64.79%259.90K
-96.91%13.06K
-96.00%36.91K
--73.66K
--157.72K
--422.08K
--922.73K
Non-current assets
Net Fixed Assets
--13.14K
----
----
----
----
----
----
----
Long-term prepaid expenses
--184.00K
----
----
----
----
----
----
----
Other non-current assets
--184.00K
----
----
----
----
----
----
----
Total non-current assets
--197.13K
----
----
----
----
----
----
----
Total assets
14217.67%10.55M
64.79%259.90K
-96.91%13.06K
-96.00%36.91K
--73.66K
--157.72K
--422.08K
--922.73K
Liabilities
Current liabilities
-Other payables
122.49%189.86K
175.40%211.60K
--183.14K
----
--85.34K
--76.83K
--0.00
--55.00K
Accrued expenses
-63.93%109.23K
1467.97%935.20K
--591.19K
----
--302.83K
--59.64K
----
----
Short-term debt and lease liabilities
400.00%500.00K
--623.62K
--250.00K
-3.85%250.00K
--100.00K
----
--0.00
--260.00K
-Short-term debt
----
--373.62K
----
----
----
----
----
----
Other current liabilities
122.49%189.86K
175.40%211.60K
--183.14K
----
--85.34K
--76.83K
--0.00
--55.00K
Total current liabilities
65.72%809.00K
1197.23%1.77M
730.67%1.02M
101.93%761.40K
--488.17K
--136.48K
--123.31K
--377.07K
Non-current liabilities
Long-term debt and lease liabilities
-100.00%0.00
-12.54%250.00K
29.96%346.84K
-19.50%321.99K
--299.46K
--285.84K
--266.89K
--400.00K
-Long-term debt
-100.00%0.00
-12.54%250.00K
29.96%346.84K
-19.50%321.99K
--299.46K
--285.84K
--266.89K
--400.00K
Total non-current liabilities
-100.00%0.00
-12.54%250.00K
29.96%346.84K
-19.50%321.99K
--299.46K
--285.84K
--266.89K
--400.00K
Total liabilities
2.71%809.00K
378.41%2.02M
251.40%1.37M
39.42%1.08M
--787.63K
--422.32K
--390.20K
--777.07K
Shareholders' equity
Common equity
466.75%17.19M
-0.00%3.03M
-0.00%3.03M
17.56%3.03M
--3.03M
--3.03M
--3.03M
--2.58M
Retained earnings
-98.96%-7.46M
-45.35%-4.79M
-46.30%-4.39M
-67.57%-4.08M
---3.75M
---3.30M
---3.00M
---2.43M
Capital reserves
503.49%17.07M
4.47%2.95M
4.47%2.95M
46.50%2.83M
--2.83M
--2.83M
--2.83M
--1.93M
Total equity
1463.89%9.74M
-565.35%-1.76M
-4361.31%-1.36M
-818.45%-1.05M
---713.97K
---264.60K
--31.87K
--145.66K
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
